… risk of ovarian cancer. They concluded that treatment with ovulation-inducing drugs did not
appear to increase the risk for ovarian cancer but its role could not be completely excluded. …

… of developing ovarian cancer irrespective of their exposure to ovulation induction medications.
… association between ovulation induction treatment of infertility and ovarian cancer risk. …

… These recent studies are in agreement with a number of smaller investigations that found
no effect of ovulation-inducing drugs on ovarian cancer risk. These have included cohort (12, …

… While results so far are re-assuring, it is clinically wise to follow the recent guidance to limit
the use of ovulation induction or ovarian stimulation agents to the lowest effective dose and …

… This association could also suggest, however, that ovulations in the 20–29-year age
group are the most influential in terms of development of ovarian cancer, reflecting the “induction …

… the ovary. Our data also supports the association between increased ovulation and the risk of
ovarian cancer. … Thus, the ovulation-induced exposure of ovarian stroma might facilitate the …

… Many of the women included in present studies of ovulation-induction agents and ovarian
cancer were using fertility drugs before 1967. Therefore, the drugs may have been different …

… of ovarian cancer rising with the ovulation induction. The case reports on the ovarian cancer
cases and the studies reporting the rising risk of cancer due to ovulation induction are also …

… between ovarian malignancies and ovulation-inducing agents. In … ovarian cancer will be
reviewed, and the possible association between ovarian carcinoma and ovulation induction …

… of the OSE associated with ovulation. The LH surge induces ovulation via the initiation of
an … Proinflammatory mediators such as IL-1 and TNFα induce HSD11B1 gene expression in …